Tandem Diabetes Care, Inc. (LON:0M0F)

Tandem Diabetes Care Statistics

Total Valuation

LON:0M0F has a market cap or net worth of GBP 611.80 million. The enterprise value is 714.04 million.

Market Cap	611.80M
Enterprise Value	714.04M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	67.57M
Shares Outstanding	n/a
Shares Change (YoY)	+1.58%
Shares Change (QoQ)	+0.97%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	61.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.84
PB Ratio	6.29
P/TBV Ratio	6.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.76
EV / Sales	0.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-126.11

Financial Position

The company has a current ratio of 2.44, with a Debt / Equity ratio of 3.41.

Current Ratio	2.44
Quick Ratio	1.76
Debt / Equity	3.41
Debt / EBITDA	n/a
Debt / FCF	-58.52
Interest Coverage	-12.42

Financial Efficiency

Return on equity (ROE) is -111.91% and return on invested capital (ROIC) is -8.96%.

Return on Equity (ROE)	-111.91%
Return on Assets (ROA)	-6.41%
Return on Invested Capital (ROIC)	-8.96%
Return on Capital Employed (ROCE)	-14.91%
Revenue Per Employee	275,907
Profits Per Employee	-56,588
Employee Count	2,650
Asset Turnover	1.10
Inventory Turnover	3.12

Taxes

In the past 12 months, LON:0M0F has paid 2.22 million in taxes.

Income Tax	2.22M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-69.97%
50-Day Moving Average	13.64
200-Day Moving Average	22.95
Relative Strength Index (RSI)	45.97
Average Volume (20 Days)	3,088

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.22

Income Statement

In the last 12 months, LON:0M0F had revenue of GBP 731.15 million and -149.96 million in losses. Loss per share was -2.26.

Revenue	731.15M
Gross Profit	384.20M
Operating Income	-67.90M
Pretax Income	-147.74M
Net Income	-149.96M
EBITDA	-55.40M
EBIT	-67.90M
Loss Per Share	-2.26

Balance Sheet

The company has 230.18 million in cash and 331.31 million in debt, giving a net cash position of -101.13 million.

Cash & Cash Equivalents	230.18M
Total Debt	331.31M
Net Cash	-101.13M
Net Cash Per Share	n/a
Equity (Book Value)	97.28M
Book Value Per Share	1.44
Working Capital	265.05M

Cash Flow

In the last 12 months, operating cash flow was 7.10 million and capital expenditures -12.76 million, giving a free cash flow of -5.66 million.

Operating Cash Flow	7.10M
Capital Expenditures	-12.76M
Free Cash Flow	-5.66M
FCF Per Share	n/a

Margins

Gross margin is 52.55%, with operating and profit margins of -9.29% and -20.51%.

Gross Margin	52.55%
Operating Margin	-9.29%
Pretax Margin	-20.21%
Profit Margin	-20.51%
EBITDA Margin	-7.58%
EBIT Margin	-9.29%
FCF Margin	n/a

Dividends & Yields

LON:0M0F does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.58%
Shareholder Yield	n/a
Earnings Yield	-24.51%
FCF Yield	-0.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0M0F has an Altman Z-Score of 0.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.99
Piotroski F-Score	4